KPIs & Operating Metrics(New)
Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityConvertible DebtCurrent AssetsCurrent Deferred RevenueCurrent LeasesFinished GoodsGoodwillGoodwill & IntangiblesIntangiblesInventoryLiabilities and Shareholders EquityNon-Current AssetsNon-Current Deffered RevenueOperating LeasesOther Accumulated ExpensesOther Non-Current AssetsPayablesPrepaid AssetsProperty, Plant & Equipment (Net)Raw MaterialsReceivablesRetained EarningsShareholder's EquityShares OutstandingShort-term InvestmentsTotal Current LiabilitiesTotal LiabilitiesTotal Non-Current LiabilitiesTreasury SharesWork In Process
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Pacific Biosciences Of California (PACB) Total Current Liabilities (2016 - 2025)

Pacific Biosciences Of California has reported Total Current Liabilities over the past 16 years, most recently at $72.8 million for Q4 2025.

  • Quarterly results put Total Current Liabilities at $72.8 million for Q4 2025, up 9.85% from a year ago — trailing twelve months through Dec 2025 was $72.8 million (up 9.85% YoY), and the annual figure for FY2025 was $72.8 million, up 9.85%.
  • Total Current Liabilities for Q4 2025 was $72.8 million at Pacific Biosciences Of California, up from $63.2 million in the prior quarter.
  • Over the last five years, Total Current Liabilities for PACB hit a ceiling of $271.4 million in Q2 2023 and a floor of $33.7 million in Q1 2021.
  • Median Total Current Liabilities over the past 5 years was $72.8 million (2025), compared with a mean of $105.1 million.
  • Biggest five-year swings in Total Current Liabilities: tumbled 74.44% in 2021 and later surged 335.46% in 2023.
  • Pacific Biosciences Of California's Total Current Liabilities stood at $71.7 million in 2021, then soared by 267.23% to $263.3 million in 2022, then tumbled by 63.91% to $95.0 million in 2023, then crashed by 30.23% to $66.3 million in 2024, then increased by 9.85% to $72.8 million in 2025.
  • The last three reported values for Total Current Liabilities were $72.8 million (Q4 2025), $63.2 million (Q3 2025), and $59.8 million (Q2 2025) per Business Quant data.